Stay updated with breaking news from Abdx l. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
4 May 2021 | 07:51am StockMarketWire.com - Oil company SDX Energy said it had commenced the first, three well, phase of its 2021 drilling campaign in Morocco. The drilling campaign would comprise up to five wells over the year. Story provided by StockMarketWire.com Find out how to deal online from £1.50 in a SIPP, ISA or Dealing account. Latest share price and company details: ....
27 April 2021 | 08:52am StockMarketWire.com - Rapid tests manufacturer Abingdon Health warned on performance after a slower-than-expected uptake of its Covid-19 test kits. For fiscal 2021, revenue was now expected in the range of £11.4 million to £17.0 million, with an adjusted earnings before interest, taxes, depreciation and amortisation, or EBITDA in the range of -£3.3 million to £0.0 million. The speed of adoption and therefore the receipt of orders is taking longer than the board originally anticipated, the company said. The board therefore expects the results for FY21 will be substantially below the current market expectations, it added. Story provided by StockMarketWire.com ....
Share price 10 March 2021 | 14:11pm StockMarketWire.com - International developer and manufacturer of rapid tests Abingdon Health has signed a non-exclusive sales and distribution agreement in the UK and Europe for the AbC-19 rapid neutralising antibody test with BioSure UK. Under the terms of the agreement, Abingdon Health and BioSure UK intend to establish a strategic distribution relationship to enable them to identify and maximise opportunities for the sale of the rapid neutralising antibody test in the UK and European territories, prioritising healthcare, workplace and pharmacy settings. Abingdon Health chief executive Chris Yates said: The nature of SARS-CoV-2 testing is changing. Where antibody tests were once predominantly used for charting the spread of infection within communities, today they are emerging as a key pillar of large-scale immunisation campaigns. ....
9 March 2021 | 09:21am StockMarketWire.com - Developer and manufacturer of rapid tests Abingdon Health reported wider first-half losses as higher offset a jump in revenue, driven by COVID-19 tests sales. For the six months ended 31 December 2020, pre-tax losses widened to £1.571 million from £775,000, while revenue increased to £7.69 million from £1.55 million. The contract with the DHSC for the supply of COVID-19 rapid antibody test formed a substantial portion of its revenue for the period, the company said. As the business upscales its activities to reach its capacity plans, overhead costs have also increased, predominantly in staff costs (£2.29m) and professional fees (£0.34m), it added. ....